TSXV - Delayed Quote CAD
Waverley Pharma Inc. (WAVE.V)
At close: October 15 at 1:36 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-1,049.4500
-1,021.1150
-237.0630
-798.7780
-361.7050
--
Investing Cash Flow
--
--
-226.6250
--
--
--
Financing Cash Flow
968.4440
940.3330
439.3700
222.3560
-373.6550
--
End Cash Position
54.1090
53.0150
133.7970
158.1150
710.4920
--
Issuance of Debt
--
940.3330
439.3700
222.3560
40.0000
--
Free Cash Flow
-1,049.4500
-1,021.1150
-237.0630
-798.7780
-361.7050
--
12/31/2019 - 10/27/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IOT.V Innovotech Inc.
0.1350
0.00%
TELI.CN Telescope Innovations Corp.
0.4500
+12.50%
CVALF Covalon Technologies Ltd.
2.2700
+1.79%
COV.V Covalon Technologies Ltd.
3.1400
-1.26%
MLEC Moolec Science SA
0.8500
-4.49%
CNSP CNS Pharmaceuticals, Inc.
0.1220
+1.84%
GANX Gain Therapeutics, Inc.
2.7000
-2.53%
TNYA Tenaya Therapeutics, Inc.
2.0400
-5.12%
RNAZ TransCode Therapeutics, Inc.
0.6131
+2.35%
EXAI Exscientia plc
5.21
+2.96%